Explore first person business intelligence from top minds curated for a global executive audience The 16th edition of the ...

A Hull-based manufacturer of laboratory furniture is set to expand its operations and workforce following a £100,000 loan ...

Royalty Pharma's Q3 results show growth driven by strong portfolio performance and acquisitions. See why we recommend a buy ...

Discussion meet on the impact of Nobel Prize winners in Economics on Indian development, focusing on institutions and democracy.

Barclays lowered the firm’s price target on GSK (GSK) to 1,450 GBp from 1,550 GBp and keeps an Equal Weight rating on the shares.